Novel blood test predicts kidney cancer risk and survival five years prior to diagnosis

(Brigham and Women's Hospital) In a new study published in Clinical Cancer Research, investigators explore whether a blood test can detect higher concentrations of KIM-1 in patients who will go on to develop kidney cancer up to five years later. Their results show that KIM-1 substantially helped distinguish between those who went on to develop kidney cancer from those who did not.